Public Employees Retirement System of Ohio trimmed its position in USANA Health Sciences, Inc. (NYSE:USNA) by 3.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,897 shares of the company’s stock after selling 437 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in USANA Health Sciences were worth $698,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Alps Advisors Inc. grew its stake in USANA Health Sciences by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 8,349 shares of the company’s stock worth $535,000 after buying an additional 22 shares during the last quarter. California State Teachers Retirement System grew its stake in USANA Health Sciences by 0.5% during the 2nd quarter. California State Teachers Retirement System now owns 20,582 shares of the company’s stock worth $1,319,000 after buying an additional 100 shares during the last quarter. JPMorgan Chase & Co. grew its stake in USANA Health Sciences by 1.2% during the 1st quarter. JPMorgan Chase & Co. now owns 16,044 shares of the company’s stock worth $924,000 after buying an additional 196 shares during the last quarter. BNP Paribas Arbitrage SA grew its stake in USANA Health Sciences by 13.1% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock worth $135,000 after buying an additional 245 shares during the last quarter. Finally, Legal & General Group Plc grew its stake in USANA Health Sciences by 7.6% during the 2nd quarter. Legal & General Group Plc now owns 4,040 shares of the company’s stock worth $259,000 after buying an additional 284 shares during the last quarter. Institutional investors and hedge funds own 44.62% of the company’s stock.

In other USANA Health Sciences news, major shareholder Global Ltd Gull sold 43,292 shares of the business’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $65.25, for a total transaction of $2,824,803.00. Following the completion of the transaction, the insider now owns 12,053,403 shares in the company, valued at approximately $786,484,545.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider James Bramble sold 18,298 shares of the business’s stock in a transaction on Monday, August 21st. The stock was sold at an average price of $57.01, for a total value of $1,043,168.98. Following the transaction, the insider now owns 20,374 shares of the company’s stock, valued at approximately $1,161,521.74. The disclosure for this sale can be found here. Insiders have sold a total of 542,489 shares of company stock valued at $33,489,137 in the last quarter. 53.20% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: “USANA Health Sciences, Inc. (USNA) Shares Sold by Public Employees Retirement System of Ohio” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/11/12/usana-health-sciences-inc-usna-shares-sold-by-public-employees-retirement-system-of-ohio.html.

USANA Health Sciences, Inc. (NYSE USNA) opened at $65.40 on Friday. The company has a market capitalization of $1,569.14, a price-to-earnings ratio of 17.30 and a beta of 1.07. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $71.00.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, October 24th. The company reported $1.02 EPS for the quarter, topping the Zacks’ consensus estimate of $0.91 by $0.11. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. The firm had revenue of $261.77 million during the quarter, compared to the consensus estimate of $259.52 million. During the same period in the prior year, the business earned $2.40 EPS. The firm’s revenue was up 3.0% on a year-over-year basis. sell-side analysts forecast that USANA Health Sciences, Inc. will post 3.7 EPS for the current year.

USANA Health Sciences declared that its Board of Directors has initiated a share buyback program on Tuesday, July 25th that allows the company to buyback $64.60 million in shares. This buyback authorization allows the company to buy up to 46% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s board believes its stock is undervalued.

A number of brokerages recently commented on USNA. BidaskClub downgraded USANA Health Sciences from a “hold” rating to a “sell” rating in a research note on Thursday, November 2nd. Pivotal Research upped their price objective on USANA Health Sciences from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Wednesday, October 25th.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Stock Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related stocks with our FREE daily email newsletter.